ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 315

$2.07M Total Retail Price of All Prescriptions

Rank: 2 out of 315

334 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 4,526 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$218 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
HYDROCODONE-ACETAMINOPHEN 348 76 S3 1 19
SIMVASTATIN 313 282 2 1
LISINOPRIL 289 193 3 3
METFORMIN HCL 238 214 4 7
LOSARTAN POTASSIUM 214 180 5 4
LEVOTHYROXINE SODIUM 200 92 6 6
ATORVASTATIN CALCIUM 185 133 7 5
TRUVADA 181 0 8 161
LOVASTATIN 161 147 9 8
OMEPRAZOLE 150 89 10 9
IBUPROFEN 143 23 11 89
ATRIPLA 139 61 12 196
PRAVASTATIN SODIUM 137 74 13 10
NORVIR 136 11 14 177
ACYCLOVIR 133 16 15 201
OXYCODONE HCL 130 24 S2 16 57
ZOLPIDEM TARTRATE 121 50 17 29
ISENTRESS 114 12 18 186
GABAPENTIN 111 27 19 37
CEPHALEXIN 111 69 19 109
ATENOLOL 100 88 21 11
DONEPEZIL HCL 95 59 22 28
LOPERAMIDE 94 21 23 159
ADVAIR DISKUS 91 48 24 46
PREZISTA 90 12 25 208
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 28 26 149
FUROSEMIDE 85 49 27 15
KALETRA 82 0 28 278
LIPITOR 80 38 29 44
VIREAD 79 0 30 232
DILTIAZEM 24HR ER 79 71 30 90
TAMSULOSIN HCL 76 47 32 21
GLYBURIDE 75 71 R 33 49
DRONABINOL 72 0 34 288
METHOCARBAMOL 70 18 R 35 291
VALACYCLOVIR 70 0 35 244
RANITIDINE HCL 69 36 37 42
METOPROLOL SUCCINATE 68 48 38 13
TRIAMCINOLONE ACETONIDE 68 46 38 62
ALENDRONATE SODIUM 65 53 40 12
AMLODIPINE BESYLATE 64 64 41 2
FLUTICASONE PROPIONATE 63 31 42 53
REYATAZ 62 0 43 223
CYCLOBENZAPRINE HCL 60 33 R 44 168
DIDANOSINE 60 0 44 308
CITALOPRAM HBR 58 22 46 72
LYRICA 58 25 46 126
MELOXICAM 55 48 48 77
OXYCONTIN 53 14 S2 49 192
ZIAGEN 53 0 49 321
PAROXETINE HCL 52 34 51 142
METOPROLOL TARTRATE 52 51 51 18
WARFARIN SODIUM 52 41 51 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.